US
Urmila Singh
About Urmila Singh
Data last updated:
Urmila Singh is a Director at Spindigital Private Limited (since 2019) and Director at Nucleotide Private Limited (since 2022). The companies operate in Business Services and Research & Development. The 2 current companies with reported revenue have a combined latest revenue of ₹8.9 Lakh; the largest is Spindigital Private Limited at ₹6 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 18 Feb 2019 | 2019 | ₹6 Lakh (FY 2025) | Active | |
| Director | 21 Feb 2022 | 2022 | ₹2.9 Lakh (FY 2025) | Active |
Board colleagues of Urmila Singh
| Name | DIN | Company | Designation |
|---|---|---|---|
| Arti | 08365672 | Spindigital Private Limited | Director |
| Prem Prakash | 09513528 | Nucleotide Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Urmila Singh
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Urmila Singh
Urmila Singh currently holds 2 directorships: Spindigital Private Limited (Director, since 18 Feb 2019, revenue ₹6 Lakh (FY 2025)); Nucleotide Private Limited (Director, since 21 Feb 2022, revenue ₹2.9 Lakh (FY 2025)).
Urmila Singh was first appointed on 18 Feb 2019 as Director at Spindigital Private Limited. The most recent appointment on record is 21 Feb 2022 at Nucleotide Private Limited.
The 2 current companies of Urmila Singh that report revenue have a combined latest revenue of ₹8.9 Lakh: Spindigital Private Limited ₹6 Lakh (FY 2025); Nucleotide Private Limited ₹2.9 Lakh (FY 2025).
The current boards of Urmila Singh's companies include Arti (Spindigital Private Limited), Prem Prakash (Nucleotide Private Limited).